APA

Mattioli R., Lippe P., Massacesi C., Cappelletti C., Nacciarriti D., Bisonni R., Graziano F., Menichetti E. T., Imperatori L., Testa E., Laici G., Balletra A. & Silva R. R. (20041130). Long-survival in responding patients with metastatic breast cancer treated with doxorubicin-docetaxel combination. A multicentre phase II trial. : Anticancer research.

Chicago

Mattioli R, Lippe P, Massacesi C, Cappelletti C, Nacciarriti D, Bisonni R, Graziano F, Menichetti E T, Imperatori L, Testa E, Laici G, Balletra A and Silva R R. 20041130. Long-survival in responding patients with metastatic breast cancer treated with doxorubicin-docetaxel combination. A multicentre phase II trial. : Anticancer research.

Harvard

Mattioli R., Lippe P., Massacesi C., Cappelletti C., Nacciarriti D., Bisonni R., Graziano F., Menichetti E. T., Imperatori L., Testa E., Laici G., Balletra A. and Silva R. R. (20041130). Long-survival in responding patients with metastatic breast cancer treated with doxorubicin-docetaxel combination. A multicentre phase II trial. : Anticancer research.

MLA

Mattioli R, Lippe P, Massacesi C, Cappelletti C, Nacciarriti D, Bisonni R, Graziano F, Menichetti E T, Imperatori L, Testa E, Laici G, Balletra A and Silva R R. Long-survival in responding patients with metastatic breast cancer treated with doxorubicin-docetaxel combination. A multicentre phase II trial. : Anticancer research. 20041130.